Abbott Laboratories buy Argus
Start price
31.01.25
/
50%
€123.82
Target price
31.01.26
-
Performance (%)
-25.46%
End price
01.02.26
€92.30
Summary
This prediction ended on 01.02.26 with a price of €92.30. The price of Abbott Laboratories has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -25.46%. Argus has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Abbott Laboratories | -4.137% | -4.137% | -23.015% |
| iShares Core DAX® | 2,55 % | -0,11 % | 15,00 % |
| iShares Nasdaq 100 | 2,74 % | -0,47 % | 30,95 % |
| iShares Nikkei 225® | 6,58 % | 3,22 % | 49,70 % |
| iShares S&P 500 | 1,93 % | -0,52 % | 24,88 % |
Comments by Argus for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE: ABT) was upgraded by analysts at Argus to a "strong-buy" rating.
Ratings data for ABT provided by MarketBeat
In the thread Trading Abbott Laboratories
Die von Argus gewählte maximale Laufzeit wurde überschritten